Dr Brian Gardner


Research Fellow in Computational Biology

Academic and research departments

School of Veterinary Medicine.

About

Research

Research interests

Publications

Brian Gardner, Giovanni Lo Iacono (2025)Modelling the resilience of the gut microbiome University of Surrey

Gut microbiota are essential for maintaining host health, for example by providing protection against pathogens. This has prompted numerous studies to explore the composition and diversity of microbial communities using metagenomics techniques. Although this allows some degree of insight, there remains a shortcoming in understanding the interactions and temporal dynamics of these communities in greater detail. Moreover, this knowledge gap becomes further pronounced as we also consider the impact of external perturbations, for example antibiotic treatment, on the long-term stability of these microbial communities. To address this, we developed a mechanistic modelling framework based on the generalised Lotka–Volterra model to predict microbial compositional changes over time and to assess its sensitivity to applied external perturbation. Essentially, whether or not the microbial community bounces back to its original configuration once the perturbation has stopped. Using in-silico data and publicly available data derived from 16S rRNA sequencing, we estimated microbial growth rates and their mutual interactions. This model relies on absolute abundance counts, which can be estimated from total microbial biomass measurements, and the data is organised into the topmost abundant taxa organised at the genus level to prevent over-fitting. Bayesian inference was used to estimate model parameters from these abundance counts. Perturbations were represented by imposing seasonal changes in microbial growth rates that fluctuated about their non-perturbed values. After fitting the model to these datasets, we explored different applications of the perturbation signal and evaluated its impact on the long-term stability of the community dynamics. The model shows that, even if the intensity of the perturbation is the same (e.g., a given dosage of antibiotics), there are specific frequencies at which the perturbation is administered that can cause pronounced responses (resonance). Essentially, we can induce large deviations in microbial abundances from their equilibrium values and even drive some taxa to extinction. Applications of this approach include identifying optimal antibiotic treatment regimens to minimise the emergence of superbugs resistant to antibiotics and informing personalised strategies for maintaining a healthy gut microbiota.

Inaki Deza-Cruz, Alexandre de Menezes, Brian Gardner, Ilknur Aktan, Sarhad Alnajjar, Martha Elizabeth Betson, Adriana Cabal Rosel, Manuela Caniça, Mark Chambers, Georgina Tarrant, Francesca Marie Contadini, Olukayode Daramola, Rani de la Rivière, Mary Bernadette Egan, Abel Bulamu Ekiri, Catherine Finnegan, Laura Cristina Gonzalez Villeta, Richard Green, Belinda Suzette Hall, Martin Hawes, Marwa Hassan, Sara Healy, Lisa Marie Holbrook, Guldane Damla Kaya, Prashant Kumar, Roberto Marcello La Ragione, Daniel James Maupin, Jai W. Mehat, Davide Messina, Kelly Moon, Elizabeth Mumford, Gordon Nichols, Daniel V. Olivença, Joaquin Prada, Claire Price, Christopher John Proudman, Retha Queenan, Miguel Ramos, Jaime Riccomini Closa, Jennifer M. Ritchie, Lorenzo Santorelli, Nick Selemetas, Matt Spick, Yashwanth Subbannayya, Shelini Surendran, Pedro Teixeira, Mukunthan Tharmakulasingam, Damian Valle, Arnoud H. M. Van Vliet, Marco Videira, Hazel Wallace-Williams, Klara Wanelik, Markus Woegerbauer, Danika Wright, Giovanni Lo Iacono (2025)Mapping the evidence of the effects of environmental factors on the prevalence of antibiotic resistance in the non-built environment, In: Environment International202109634 Elsevier

Background: Antibiotic resistance increasingly threatens the interconnected health of humans, animals, and the environment. While misuse of antibiotics is a known driver, environmental factors also play a critical role. A balanced One Health approach—including the environmental sector—is necessary to understand the emergence and spread of resistance. Methods: We systematically searched English-language literature (1990–2021) in MEDLINE, Embase, and Web of Science, plus grey literature. Titles, abstracts, and keywords were screened, followed by full-text reviews using a structured codebook and dual-reviewer assessments. Results: Of 13,667 records screened, 738 met the inclusion criteria. Most studies focused on freshwater and terrestrial environments, particularly associated with wastewater or manure sources. Evidence of research has predominantly focused on Escherichia coli and Pseudomonas spp., with a concentration on ARGs conferring resistance to sulphonamides (sul1–3), tetracyclines (tet), and beta-lactams. Additionally, the People’s Republic of China has produced a third of the studies—twice that of the next country, the United States—and research was largely domestic, with closely linked author networks. Conclusion: Significant evidence gaps persist in understanding antibiotic resistance in non-built environments, particularly in marine, atmospheric, and non-agricultural set65 tings. Stressors such as climate change and microplastics remain notably under-explored. There is also an urgent need for more research in low-income regions, which face higher risks of antibiotic resistance, to support the development of targeted, evidence-based interventions.

Brian Gardner, Laura C. Gonzalez Villeta, Joy Leng, Marwa M. Hassan, Mark Chambers, Roberto M. La Ragione, Giovanni Lo Iacono (2022)Mechanistic modelling of microbial communities with insights from an in vitro pig gut model Zenodo

The gut microbiota play a key role in the health of animals and humans. However, the dynamic properties and stability of the microbiota are poorly understood. We propose a regression technique for parameter inference of a mechanistic model to describe the temporal dynamics of these microbial communities. The model could be used for measuring community resilience against external perturbing factors, such as antibiotic therapy.